Clinical Proof-of-concept of a Novel Platform Utilizing Biopsy-derived Live Single Cells, Phenotypic Biomarkers, and Machine Learning Toward a Precision Risk Stratification Test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3 + 3 and 3 + 4)
| Autor: | Albala, David, Manak, Michael S., Varsanik, Jonathan S., Rashid, Hani H., Mouraviev, Vladimir, Zappala, Stephen M., Ette, Ene, Kella, Naveen, Rieger-Christ, Kimberly M., Sant, Grannum R., Chander, Ashok C. |
|---|---|
| Zdroj: | In Urology February 2019 124:198-206 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect